Furthermore, PRM data showed that plasma sEV LAMB1 expression can significantly distinguish mPCa from high‐risk PCa, and sEV protein Histone H4 expression in urine can distinguish PCa patients with high‐risk versus low‐risk. This evidence concerns the gene LAMB1 and posterior cortical atrophy.